The disclaimer statement was not included in the following previously published articles in iLIVER.
-
•
The author Tian Yang is Executive Editor-in-Chief and Guoyue Lv is an Editorial Board Member for this journal and were not involved in the editorial review or the decision to publish this article.
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
https://doi.org/10.1016/j.iliver.2024.100083
Volume 3, Issue 1, 2024
-
•
The co-author Hai-Ning Fan is an Editorial Board Member for this journal and was not involved in the editorial review or the decision to publish this article.
Anatomical hepatectomy for achieving textbook outcome for perihilar cholangiocarcinoma treated with curative-intent resection: A multicenter study
https://doi.org/10.1016/j.iliver.2022.10.004
Volume 1 Issue 4, 2022
-
•
The author Haining Fan is an Editorial Board Member for this journal and was not involved in the editorial review or the decision to publish this article.
Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review
https://doi.org/10.1016/j.iliver.2022.10.001
Volume 1 Issue 4, 2022
-
•
The co-author Jia Fan is Co-Editor-in-Chief for this journal and was not involved in the editorial review or the decision to publish this article.
Myeloid-derived suppressor cells in cancer
https://doi.org/10.1016/j.iliver.2022.06.002
Volume 1 Issue 2, 2022
-
•
The author Pierre-Alain Clavien is an Co-Editor-in-Chief for this journal and was not involved in the editorial review or the decision to publish this article.
Liver transplantation for malignant liver tumors
https://doi.org/10.1016/j.iliver.2022.04.002
Volume 1 Issue 1, 2022
-
•
The author Jia Fan is Co-Editor-in-Chief and Jian Zhou is an Editorial Board Member for this journal and were not involved in the editorial review or the decision to publish this article.
Associating liver partition and portal vein ligation for staged hepatectomy for colorectal liver metastasis: a single-center experience
https://doi.org/10.1016/j.iliver.2022.02.002
Volume 1 Issue 1, 2022
-
•
The co-author Jiahong Dong is Editor-in-Chief, Shizhong Yang and Yuewei Zhang are Editorial Board Members, and Qian Lu is an Executive Assistant Editor for this journal. They were not involved in the editorial review or the decision to publish this article.
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
https://doi.org/10.1016/j.iliver.2022.01.001
Volume 1 Issue 1, 2022
-
•
The co-author Jiahong Dong is Editor-in-Chief, Shizhong Yang is an Editorial Board Member for this journal and were not involved in the editorial review or the decision to publish this article.
Radiomic features on contrast-enhanced images of the remnant liver predict the prognosis of hepatocellular carcinoma after partial hepatectomy
https://doi.org/10.1016/j.iliver.2024.100079
Volume 3, Issue 1, 2024